[Infectious mononucleosis and ampicillin]

Insights

Ampicillin use in patients with infectious mononucleosis (IM) significantly increases the risk of cutaneous reactions, with unknown mechanisms. Ruling out IM is crucial before prescribing ampicillin for pharyngeal symptoms.

Area of Science:

  • Pharmacology
  • Dermatology
  • Infectious Diseases

Background:

  • Ampicillin commonly causes cutaneous reactions in 1-10% of patients.
  • Infectious mononucleosis (IM) is frequently associated with ampicillin, leading to a dramatic increase in cutaneous reactions, up to 90% of cases.
  • The underlying physiopathogenic mechanism for this ampicillin-induced exanthema in IM patients remains unclear.

Observation:

  • Patients experiencing these reactions often lack a prior history of penicillin allergy.
  • The observed cutaneous reactions present as mild exanthema, not solely attributable to IM.
  • The reaction pattern differs from typical ampicillin-induced allergic responses, suggesting a unique interaction.

Findings:

  • A strong clinical association exists between ampicillin administration and cutaneous reactions in patients with IM.
  • Phototoxicity is suspected due to sun-exposed areas being primarily affected, though tests were negative.
  • The data suggest IM may predispose or alter patient sensitivity to ampicillin, triggering reactions.

Implications:

  • Ampicillin administration is contraindicated in patients with undiagnosed pharyngeal symptoms until infectious mononucleosis is ruled out.
  • Further research is needed to elucidate the specific mechanisms behind ampicillin-induced cutaneous reactions in the context of IM.
  • This finding highlights the importance of careful patient evaluation and drug selection in managing infectious mononucleosis.